Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited)

v3.20.2
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Total
Common Stock
Paid in Capital
Retained Earnings
Beginning Balances at Dec. 31, 2018 $ 37,205,876 $ 76,926 $ 33,961,903 $ 3,167,047
Beginning Balance, shares at Dec. 31, 2018   7,692,624    
Restricted stock grants issued   $ 414 (414)  
Restricted stock grants issued, Shares   41,343    
Stock-based compensation 54,160   54,160  
Net income (loss) 187,823     187,823
Dividends (503,294)     (503,294)
Ending Balance at Mar. 31, 2019 36,944,565 $ 77,340 34,015,649 2,851,576
Ending Balance, shares at Mar. 31, 2019   7,733,967    
Beginning Balances at Dec. 31, 2018 37,205,876 $ 76,926 33,961,903 3,167,047
Beginning Balance, shares at Dec. 31, 2018   7,692,624    
Net income (loss) 573,901      
Ending Balance at Sep. 30, 2019 36,407,011 $ 77,290 34,096,859 2,232,862
Ending Balance, shares at Sep. 30, 2019   7,729,006    
Beginning Balances at Mar. 31, 2019 36,944,565 $ 77,340 34,015,649 2,851,576
Beginning Balance, shares at Mar. 31, 2019   7,733,967    
Restricted stock grant forfeitures   $ (47) 47  
Restricted stock grant forfeitures, shares   (4,637)    
Stock-based compensation 51,730   51,730  
Net income (loss) 136,845     136,845
Dividends (502,407)     (502,407)
Ending Balance at Jun. 30, 2019 36,630,733 $ 77,293 34,067,426 2,486,014
Ending Balance, shares at Jun. 30, 2019   7,729,330    
Restricted stock grant forfeitures   $ (3) 3  
Restricted stock grant forfeitures, shares   (324)    
Stock-based compensation 29,430   29,430  
Net income (loss) 249,233     249,233
Dividends (502,385)     (502,385)
Ending Balance at Sep. 30, 2019 36,407,011 $ 77,290 34,096,859 2,232,862
Ending Balance, shares at Sep. 30, 2019   7,729,006    
Beginning Balances at Dec. 31, 2019 $ 42,065,916 $ 93,303 40,329,502 1,643,111
Beginning Balance, shares at Dec. 31, 2019 9,330,297 9,330,297    
Restricted stock grants issued   $ 259 (259)  
Restricted stock grants issued, Shares   25,905    
Stock-based compensation $ 29,162   29,162  
Net income (loss) (356,424)     (356,424)
Dividends (606,469)     (606,469)
Ending Balance at Mar. 31, 2020 41,132,185 $ 93,562 40,358,405 680,218
Ending Balance, shares at Mar. 31, 2020   9,356,202    
Beginning Balances at Dec. 31, 2019 $ 42,065,916 $ 93,303 40,329,502 1,643,111
Beginning Balance, shares at Dec. 31, 2019 9,330,297 9,330,297    
Net income (loss) $ (41,444)      
Ending Balance at Sep. 30, 2020 $ 40,301,458 $ 93,562 40,429,005 (221,109)
Ending Balance, shares at Sep. 30, 2020 9,356,202 9,356,202    
Beginning Balances at Mar. 31, 2020 $ 41,132,185 $ 93,562 40,358,405 680,218
Beginning Balance, shares at Mar. 31, 2020   9,356,202    
Stock-based compensation 35,317   35,317  
Net income (loss) (22,144)     (22,144)
Dividends (608,154)     (608,154)
Ending Balance at Jun. 30, 2020 40,537,204 $ 93,562 40,393,722 49,920
Ending Balance, shares at Jun. 30, 2020   9,356,202    
Stock-based compensation 35,283   35,283  
Net income (loss) 337,124     337,124
Dividends (608,153)     (608,153)
Ending Balance at Sep. 30, 2020 $ 40,301,458 $ 93,562 $ 40,429,005 $ (221,109)
Ending Balance, shares at Sep. 30, 2020 9,356,202 9,356,202